SCHEMBL9638683

SCHEMBL9638683

N#CC(C(=O)NC1CCC1)C(=O)C1CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.36
POLB P06746 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
EPHX1 P07099 5/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
MAPT P10636 3/20 0.35
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 2/20 0.35
CYP3A4 P08684 1/20 0.35
EPHX2 P34913 1/20 0.35
MMP2 P08253 1/20 0.35
MMP8 P22894 1/20 0.35
MAPK10 P53779 1/20 0.35
TSHR P16473 1/20 0.35
CASP1 P29466 3/20 0.34
KMT2A Q03164 2/20 0.34
HSD17B10 Q99714 2/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9639801 0.93 KMT2A (0.37) GAAPOLBTDP1MAPTKDM4E
SCHEMBL9639039 0.77 ALDH1A1 (0.30) GAAPOLBKDM4EALDH1A1
SCHEMBL9638528 0.77
SCHEMBL9638558 0.72 DPP4 (0.33) POLBSMN1; SMN2LMNA
SCHEMBL9639841 0.71 CAPN1 (0.34) POLBMAPT
SCHEMBL6535681 0.70 EPHX1 (0.31) GAAEPHX1
SCHEMBL9639879 0.70 KDM4E (0.31) KDM4EALDH1A1
SCHEMBL27991910 0.69 ATM (0.46) GAAEPHX1SMN1; SMN2NPC1RAB9A
SCHEMBL9638540 0.69 KMT2A (0.50) POLBSMN1; SMN2MAPTKDM4EALDH1A1
SCHEMBL16453645 0.68 ATM (0.49) EPHX1SMN1; SMN2NPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0326107-B1 ANTIARTHRITIC BETA-CYCLOALKYL-BETA-OXOPROPIONITRILES Bristol-Myers Squibb Company (US) 1992-09-02 EP disclosed
US-4888357-A ANTIINFLAMMATORY AGENTS BRISTOL-MYERS COMPANY (US) 1989-12-19 US disclosed
EP-0326107-A1 Antiarthritic beta-cycloalkyl-beta-oxopropionitriles Bristol-Myers Squibb Company (US) 1989-08-02 EP disclosed